Newsletter | November 7, 2008

11.7.08 -- Aureus Pharma To Participate In A European Consortium For Drug Cardiac Toxicity

www.drugdiscoveryonline.com
Top News Stories
Aureus Pharma To Participate In A European Consortium For Drug Cardiac Toxicity
Aureus Pharma, a leading provider of knowledge management solutions that accelerate life science discovery, announced today that they will participate in a consortium along with a number of industrial and academic research teams in a European Commission funded project entitled "preDiCT: Computational Prediction of Drug Cardiac Toxicity"...

Global Drug Discovery Technologies Market To Exceed $57B By 2012, According To A New Report By Global Industry Analysts
Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D...

Spectrum Pharmaceuticals To Present At The Rodman & Renshaw 10th Annual Global Healthcare Investment Conference
Spectrum Pharmaceuticals, Inc., announced today that an overview of the Company's business strategy will be presented at the Rodman & Renshaw Annual 10th Annual Global Healthcare Investment Conference, on Tuesday, November 11, 2008, at 12:00 p.m. Eastern...

SurModics Acquires Drug Delivery Assets Of PR Pharmaceuticals
SurModics, Inc., a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc...

Progenics Selects Small-Molecule Hepatitis C Drug Candidate For Clinical Development
Progenics Pharmaceuticals, Inc.,today announced the selection of a proprietary small-molecule drug candidate, designated PRO 206, for clinical development as a treatment of hepatitis C virus (HCV) infection...

AgilityBio And Advinus Announce Partnership To Introduce Digital Pathology Services In Pre Clinical Research
AgilityBio, a division of BioImagene Inc, and Advinus Therapeutics, a TATA enterprise, announced a partnership that will enable providing imaging services in conjunction with preclinical development services offered by Advinus...

Tripos International Completes Acquisition Of Pharsight Corporation
Tripos International, the leading provider of drug discovery informatics products and services, today announced that it has completed the acquisition of Pharsight Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development...

Thermo Fisher Scientific To Collaborate With Genentech On Novel Technology Enabling Development Of siRNA Therapeutics
Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a collaboration with Genentech, Inc. to develop novel small-interfering RNA (siRNA) therapeutic technologies for indications of interest to Genentech...

Akorn, Inc. Announces FDA Approval Of Adenosine Injection USP, 3 mg/mL
Akorn, Inc., today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug Application (ANDA) for Adenosine Injection USP, 3 mg/mL...

Featured Products
R4 Random Access Evaporator
The Genevac R4 Random Access Evaporator was the first product to offer drug discovery chemists the benefit of centrifugal evaporation combined with "open access" or 'walk-up' operation ...

Electrophysiology Module- SigmaPlot®
Electrophysiology Module is an add-on to SigmaPlot 2000 that allows you to directly import your acquired data into SigmaPlot, without the need for an additional data acquisition program. The module allows you to instantly read large data files into SigmaPlot, so you can start analyzing and graphing your data in no time...

Newsletter Subscription
If you do not currently receive the Drug Discovery Online newsletter and wish to become a subscriber, click here.
Advertise Online
If you are interested in advertising with Drug Discovery Online, click here for more information.